Literature DB >> 33112561

Scorpion and Frog Organ Lysates are Potential Source of Antitumour Activity.

Morhanavallee Soopramanien1, Naveed Ahmed Khan2, Sumayah Abdelnasir Osman Abdalla1, K Sagathevan1, Ruqaiyyah Siddiqui2.   

Abstract

OBJECTIVES: It is noteworthy that several animal species are known to withstand high levels of radiation, and are exposed to heavy metals but rarely been reported to develop cancer. For example, the scorpion has been used as folk medicine in ancient civilizations of Iran and China, while amphibian skin is known to possess medicinal properties. Here, we elucidated the anti-tumour activity of the scorpion (Uropygi) and frog (Lithobates catesbeianus).
MATERIALS AND METHODS: Animals were procured and their organ lysates and sera were prepared and tested against Michigan Cancer Foundation-7 breast cancer (MCF-7), prostate cancer (PC3), Henrietta Lacks cervical cancer (HeLa), and normal human keratinocyte cells. Exoskeleton, appendages and hepatopancreas were dissected from the scorpion, whereas liver, lungs, heart, oviduct, gastrointestinal tract, gall bladder, kidneys, eggs and sera were collected from frog and organ lysates/sera were prepared. Growth inhibition assays and cytotoxicity assays were performed.
RESULTS: Appendages, exoskeleton lysates, and hepatopancreas from scorpion exhibited potent growth inhibition, and cytotoxic effects. Furthermore, lungs, liver, gastrointestinal tract, heart, oviduct, kidneys, eggs, and sera from frog displayed growth inhibition and cytotoxic effects.
CONCLUSION: Organ lysates, sera of scorpion, and amphibians possess anti-tumour activities. This is a worthy area of research as the molecular identity of the active molecule(s) together with their mechanism of action will lead to the rational development of novel anticancer agent(s).

Entities:  

Keywords:  Cytotoxicity; Scorpion; anticancer effects; frog; growth inhibition

Mesh:

Substances:

Year:  2020        PMID: 33112561      PMCID: PMC7798147          DOI: 10.31557/APJCP.2020.21.10.3011

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  28 in total

1.  History of Cancer, Ancient and Modern Treatment Methods.

Authors:  Akulapalli Sudhakar
Journal:  J Cancer Sci Ther       Date:  2009-12-01

Review 2.  Agents from amphibians with anticancer properties.

Authors:  Chuang-Xin Lu; Ke-Jun Nan; Yan Lei
Journal:  Anticancer Drugs       Date:  2008-11       Impact factor: 2.248

Review 3.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

Review 4.  Role of the microbiota in immunity and inflammation.

Authors:  Yasmine Belkaid; Timothy W Hand
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

Review 5.  Current Challenges in Cancer Treatment.

Authors:  Jon Zugazagoitia; Cristiano Guedes; Santiago Ponce; Irene Ferrer; Sonia Molina-Pinelo; Luis Paz-Ares
Journal:  Clin Ther       Date:  2016-05-02       Impact factor: 3.393

6.  Toad skin extract cinobufatini inhibits migration of human breast carcinoma MDA-MB-231 cells into a model stromal tissue.

Authors:  Munehiro Nakata; Shuya Mori; Yo Kamoshida; Shota Kawaguchi; Yoko Fujita-Yamaguchi; Bo Gao; Wei Tang
Journal:  Biosci Trends       Date:  2015-08       Impact factor: 2.400

Review 7.  A research update on the anticancer effects of bufalin and its derivatives.

Authors:  Yu-Long Lan; Jia-Cheng Lou; Xue-Wen Jiang; Xun Wang; Jin-Shan Xing; Shao Li; Bo Zhang
Journal:  Oncol Lett       Date:  2019-02-21       Impact factor: 2.967

8.  Exploring Host-Microbiome Interactions using an in Silico Model of Biomimetic Robots and Engineered Living Cells.

Authors:  Keith C Heyde; Warren C Ruder
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

Review 9.  Pleiotropic Anticancer Properties of Scorpion Venom Peptides: Rhopalurus princeps Venom as an Anticancer Agent.

Authors:  Arthur G Mikaelian; Eric Traboulay; Xiaofei Michael Zhang; Emma Yeritsyan; Peter L Pedersen; Young Hee Ko; Khalid Z Matalka
Journal:  Drug Des Devel Ther       Date:  2020-02-27       Impact factor: 4.162

10.  A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.

Authors:  Xiaoling Chen; Luyao Zhang; Chengbang Ma; Yingqi Zhang; Xinping Xi; Lei Wang; Mei Zhou; James F Burrows; Tianbao Chen
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

View more
  1 in total

1.  Novel Plant-Based Metabolites as Disinfectants against Acanthamoeba castellanii.

Authors:  Ruqaiyyah Siddiqui; Noor Akbar; Bushra Khatoon; Muhammad Kawish; Muhammad Shaiq Ali; Muhammad Raza Shah; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.